Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Current and emerging therapies for knee osteoarthritis: From conventional approaches to machine learning and stem cell innovations

Cowman AW., Tang JN., Deng J., Abu-Halawa A., Jin H., Liu CZ.

Narrative Review on Knee Osteoarthritis, Osteoarthritis, Cartilage Damage, Immune Modulation, published in Regen Ther (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Regen Ther (2026)
Reported sample size
—
Source database
Europe PMC
PMID
42077270
PMCID
PMC13133973
DOI
10.1016/j.reth.2026.101106

Abstract (original English)

Osteoarthritis is characterized by cartilage degradation and joint distortion. The most prevalent version of osteoarthritis, knee osteoarthritis (KOA), affects millions, acting as a leading cause of disability. With the average life expectancy continuing to grow, the global burden of KOA is expected to increase. KOA involves chronic pain that limits function and adversely impacts patients' quality of life. Long-term management is costly and burdensome, often requiring continuous treatment that only delays disease progression unless patients receive a total knee arthroplasty. Recently, traditional treatment modalities for KOA have been augmented by advancements in machine learning (ML), which enable automated disease grading, predictive modeling for early diagnosis, and personalized treatment strategies, alongside growing interest in stem cell-based therapies. With the goal of developing less invasive treatments that slow or reverse KOA progression, investigation into these novel therapies have increased. Stem cell-based therapies offer the potential to modulate inflammation, reduce pain, and preserve cartilage integrity, addressing key limitations of existing treatments. Mesenchymal stem cells have shown promising preclinical and clinical results, demonstrating improvements in pain, function, and cartilage-related outcomes through immunomodulatory and paracrine mechanisms. This

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research